Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
IMCAS World CongressIMCAS World Congress
Not Confirmed
Not Confirmed
29-31 January, 2026
IMCAS World CongressIMCAS World Congress
Not Confirmed
Not Confirmed
29-31 January, 2026
34th NZW-Hamburg34th NZW-Hamburg
Not Confirmed
Not Confirmed
30 January-01 February, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
IMCAS World CongressIMCAS World Congress
Industry Trade Show
Not Confirmed
29-31 January, 2026
IMCAS World CongressIMCAS World Congress
Industry Trade Show
Not Confirmed
29-31 January, 2026
34th NZW-Hamburg34th NZW-Hamburg
Industry Trade Show
Not Confirmed
30 January-01 February, 2026
Digital content

28 Mar 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/biotechnology/solaxa-announces-phase-3-clinical-trial-for-spinocerebellar-ataxia-type-27b-1006868
ABOUT THIS PAGE